Finance

Beta
Lists
NXTCL:STO
NextCell Pharma AB
SEK 1.11
-2.29%
(-0.026) 1D
Jun 3, 2:59:49 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for NXTCL...
Open
SEK 1.14
High
SEK 1.14
Low
SEK 1.08
Mkt. cap
139.56M
Avg. vol.
759.73K
Volume
66.54K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
Shares outstanding
111.39M
No. of employees
21
Open
SEK 1.14
High
SEK 1.14
Low
SEK 1.08
Mkt. cap
139.56M
Avg. vol.
759.73K
Volume
66.54K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
Shares outstanding
111.39M
No. of employees
21
News stories
From sources across the web
About NextCell Pharma AB
CEOMathias Svahn
Employees21
Founded2014
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Feb 2025
May 2025
Aug 2025
Mar 2026
Revenue
3.42M
2.26M
1.83M
2.78M
Cost of goods sold
2.57M
2.11M
1.93M
1.82M
Cost of revenue
2.57M
2.11M
2.20M
1.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.64M
9.69M
13.20M
10.88M
Operating expense
9.30M
10.50M
9.11M
11.43M
Total operating expenses
11.87M
12.62M
15.72M
13.25M
Operating income
-8.46M
-10.35M
-13.90M
-10.46M
Other non operating income
1.00
-
-1.00
79.47K
EBT including unusual items
-8.20M
-10.27M
-13.79M
-10.39M
EBT excluding unusual items
-8.20M
-10.27M
-13.79M
-10.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
20.05K
201.47K
-120.48K
-81.33K
Net income
-8.20M
-10.27M
-13.79M
-10.39M
Net profit margin
-239.96%
-454.15%
-342.26%
-373.25%
Earnings per share
-
-
-
-
Interest and investment income
260.09K
82.25K
162.24K
-
Interest expense
-492.00
-
-1.59K
-1.19K
Net interest expenses
259.60K
82.25K
109.02K
-1.19K
Depreciation and amortization charges
636.53K
615.41K
638.32K
625.24K
EBITDA
-7.82M
-9.74M
-13.26M
-9.84M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more